AKRO
Price
$51.40
Change
-$1.96 (-3.67%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
4.25B
38 days until earnings call
GLSI
Price
$9.05
Change
-$0.02 (-0.22%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
121.25M
41 days until earnings call
Interact to see
Advertisement

AKRO vs GLSI

Header iconAKRO vs GLSI Comparison
Open Charts AKRO vs GLSIBanner chart's image
Akero Therapeutics
Price$51.40
Change-$1.96 (-3.67%)
Volume$18.74K
Capitalization4.25B
Greenwich LifeSciences
Price$9.05
Change-$0.02 (-0.22%)
Volume$200
Capitalization121.25M
AKRO vs GLSI Comparison Chart in %
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. GLSI commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (AKRO: $53.36 vs. GLSI: $9.07)
Brand notoriety: AKRO and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 96% vs. GLSI: 105%
Market capitalization -- AKRO: $4.25B vs. GLSI: $121.25M
AKRO [@Biotechnology] is valued at $4.25B. GLSI’s [@Biotechnology] market capitalization is $121.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 2 TA indicator(s) are bullish while GLSI’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 2 bullish, 5 bearish.
  • GLSI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both AKRO and GLSI are a bad buy in the short-term.

Price Growth

AKRO (@Biotechnology) experienced а -1.24% price change this week, while GLSI (@Biotechnology) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

AKRO is expected to report earnings on Aug 08, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($4.25B) has a higher market cap than GLSI($121M). AKRO YTD gains are higher at: 91.804 vs. GLSI (-19.234). GLSI has higher annual earnings (EBITDA): -16.75M vs. AKRO (-264.59M). AKRO has more cash in the bank: 686M vs. GLSI (2.75M). AKRO (0) and GLSI (0) have equivalent revenues.
AKROGLSIAKRO / GLSI
Capitalization4.25B121M3,516%
EBITDA-264.59M-16.75M1,579%
Gain YTD91.804-19.234-477%
P/E RatioN/AN/A-
Revenue00-
Total Cash686M2.75M24,945%
Total Debt36.6MN/A-
FUNDAMENTALS RATINGS
AKRO: Fundamental Ratings
AKRO
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROGLSI
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMVX47.64N/A
N/A
Neuberger Berman Small Cap Growth Adv
WICGX5.87N/A
N/A
William Blair China Growth I
PGICX18.15N/A
N/A
Virtus KAR Equity Income C
NFEPX20.88N/A
N/A
Columbia Large Cap Growth Opp Inst
ANONX22.97N/A
N/A
American Century Small Cap Growth I

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-5.04%
ETNB - AKRO
60%
Loosely correlated
-0.41%
SLS - AKRO
39%
Loosely correlated
+12.31%
IDYA - AKRO
39%
Loosely correlated
-1.64%
TRDA - AKRO
38%
Loosely correlated
-2.75%
VTYX - AKRO
38%
Loosely correlated
-8.74%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+0.89%
ABOS - GLSI
48%
Loosely correlated
+3.57%
DNLI - GLSI
44%
Loosely correlated
-0.78%
CLDX - GLSI
43%
Loosely correlated
+0.30%
BEAM - GLSI
43%
Loosely correlated
+1.25%
CRSP - GLSI
43%
Loosely correlated
+4.15%
More